Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.21% | -40.87% | -75.48% | -45.72% | -118.36% |
| Total Depreciation and Amortization | 40.47% | 65.69% | 38.31% | 11.47% | -6.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.78% | 65.27% | 137.80% | 80.81% | 488.45% |
| Change in Net Operating Assets | 310.90% | -44.71% | -376.66% | -240.02% | 67.44% |
| Cash from Operations | -7.23% | -11.27% | -27.87% | -20.48% | 11.30% |
| Capital Expenditure | -517.25% | -239.22% | -92.94% | -161.97% | -83.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -98.27% | -98.87% | -98.87% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -522.07% | -862.81% | -1,034.31% | -291.11% | 45.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -243.28% | -177.85% | -308.60% | -235.96% | -71.79% |
| Issuance of Common Stock | 4.78% | 159.92% | 160.33% | 311.30% | 100.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 100.00% | 100.00% | -382.02% | -382.02% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 64.74% | -114.76% | -224.16% | -434.43% | -320.37% |
| Cash from Financing | 37.41% | 309.55% | 298.75% | 301.07% | 67.64% |
| Foreign Exchange rate Adjustments | -400.00% | -414.29% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 424.50% | 245.36% | 285.29% | 508.85% | 93.41% |